Malaisie #6449 (v.3)
Données de base
- Notifiée dans
-
G/MA/QR/N/MYS/3 24/10/2023
- Validité de la version
-
24/10/2023 -
actuelle
Version active v.3
- Membre présentant le rapport
- Malaisie
- En vigueur depuis
- Date de fin
- En vigueur
- Description générale
-
Non-automatic licensing on the import of products for the purpose of clinical trials
- Base légale nationale
-
Sale of Drugs Act 1952 [Act 368]
Control of Drugs and Cosmetics Regulations 1984 - Mécanisme administratif
-
Administered by Ministry of Health (MOH).
Details of the requirement on Malaysian Guideline for Application of Clinical Trial Import License and Clinical Trial Exemption can be accessed here:
https://www.npra.gov.my/easyarticles/images/users/1140/Malaysian-Guideline-for-Application-of-CTIL-and-CTX-7.1-Edition-16.09.2021.pdf - Entités responsables
-
Ministry of Health
- Version du SH
-
HS 2022
- Cote du document de l'OMC mentionné
Métadonnées
- Justifications au regard de l'OMC
-
XX:(a) - (a) necessary to protect public morals;
GATT 1994 (GATT 1947 provisions)
Signalé comme: Articles XX(a) and XX(b) of the GATTXX:(b) - (b) necessary to protect human, animal or plant life or health;
GATT 1994 (GATT 1947 provisions)
Signalé comme: Articles XX(a) and XX(b) of the GATT - Engagements internationaux (hors OMC)
-
- Partenaires concernés
- Partenaires non concernés
Mesures
- Restrictions signalées
- NAL
| Cote |
|---|
|
NAL
|
Lignes tarifaires
|
3001
|
3001
|
Products for the purpose of clinical trials
|
|
|
3002
|
3002
|
Products for the purpose of clinical trials
|
|
|
3003
|
3003
|
Products for the purpose of clinical trials
|
|
|
3004
|
3004
|
Products for the purpose of clinical trials
|
|
|
3005
|
3005
|
Products for the purpose of clinical trials
|
|